AGUR Provident & Training Funds Management’s Gilead Sciences GILD Stock Holding History

AGUR Provident & Training Funds Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-19,509	Closed	-$1.43M	–	7
2018 Q4	$1.43M	Hold	19,509	–	–	6.55%	8
2018 Q3	$1.43M	Hold	19,509	–	–	6.55%	8
2018 Q2	$1.38M	Hold	19,509	–	–	7.35%	8
2018 Q1	$1.34M	Hold	19,509	–	–	2.31%	10
2017 Q4	$1.4M	Hold	19,509	–	–	2.14%	10
2017 Q3	$1.38M	Hold	19,509	–	–	2.25%	10
2017 Q2	$1.38M	Hold	19,509	–	–	2.14%	12
2017 Q1	$1.32M	Sell	19,509 -31,925	-62%	-$2.24M	1.74%	17
2016 Q4	$1.41M	Buy	51,434 +31,925	+164%	+$2.37M	1.86%	18
2016 Q3	$1.54M	Hold	19,509	–	–	1.15%	18
2016 Q2	$1.63M	Buy	19,509 +8,047	+70%	+$714K	1.08%	20
2016 Q1	$1.05M	Buy	+11,462	New	+$1.03M	0.72%	28

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGUR Provident & Training Funds Management's GILD Position: Q1 2019 in Review

AGUR Provident & Training Funds Management sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 19,509 shares — an estimated $1.43M sold.

AGUR Provident & Training Funds Management first reported a position in GILD in Q1 2016 and held it in 12 quarters. The position peaked at $1.63M in Q2 2016. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

AGUR Provident & Training Funds Management reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
AGUR Provident & Training Funds Management sold 19,509 Gilead Sciences shares in Q1 2019, an estimated $1.43M.
AGUR Provident & Training Funds Management first reported a position in Gilead Sciences in Q1 2016 and held it in 12 quarters.
AGUR Provident & Training Funds Management's Gilead Sciences position peaked at $1.63M in Q2 2016.
1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on AGUR Provident & Training Funds Management's 13F filing for Q1 2019, filed 14 May 2019.